ESGIC-PLUS 50 mg / 500 mg / 40 mg Oral Tablet
RxNorm 205733
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 205733 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: ESGIC-PLUS 50 mg / 500 mg / 40 mg Oral Tablet.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SBD
Semantic Branded Drug (SBD):
Acetaminophen 500 mg / butalbital 50 mg / caffeine 40 mg Oral Tablet [Esgic]
(Atom ID: 12368348)
SY
Synonym (SY):
APAP 500 mg / butalbital 50 mg / Caffeine 40 mg Oral Tablet [Esgic]
(Atom ID: 5080867)
SY
Synonym (SY):
Esgic-Plus (APAP 500 mg / butalbital 50 mg / caffeine 40 mg) Oral Tablet
(Atom ID: 3609424)
PSN